Caris Life Sciences Inc (CAI)

$23.16 -2.04 (-8.10%)
Market Cap 7.11B
Revenue (ttm) 294.01M
Net Income (ttm) 27.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 81.96
Profit Margin 9.43%
Debt to Equity Ratio 0.79
Volume 3,680,000
Avg Vol 2,445,536
Day's Range N/A - N/A
Shares Out 282.15M
Stochastic %K 1%
Beta N/A
Analysts Strong Sell
Price Target $37.38

Company Profile

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharm...

Industry: Biotechnology
Sector: Healthcare
Phone: 866 771 8946
Fax: 866 479 4925
Address:
750 West John Carpenter Freeway, Suite 800, Irving, United States
Ron12341
Ron12341 Jan. 30 at 8:54 PM
$CAI About to test 52 weeks low. We need news from management not to be in free fall mode.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 29 at 11:12 PM
$CAI Share Price: $25.20 Contract Selected: Jul 17, 2026 $25 Calls Buy Zone: $3.06 – $3.78 Target Zone: $5.33 – $6.52 Potential Upside: 65% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Ron12341
Ron12341 Jan. 29 at 10:49 PM
$CAI it’s ping pong - $25-$27. We need to stay above $25. It will be prudent to break above $27.
0 · Reply
Ron12341
Ron12341 Jan. 29 at 5:53 PM
$CAI What a blood bath…tough day
1 · Reply
Dietl
Dietl Jan. 28 at 11:48 PM
$CAI 2026 forecast
0 · Reply
Dietl
Dietl Jan. 28 at 11:48 PM
$CAI at $996M, adjusted EBITA at 23%, which is $235M, and 47% of that as net income, I get $110M net income, or 40 cents per share, about 80% more than forecast, so I must have stretched that somewhere.
0 · Reply
Dietl
Dietl Jan. 28 at 11:36 PM
$CAI $281M in Q4 revenue with 62% GM, and about $120M in opex, which is about $54M in net income. They have added $43M to cash in Q4. 22 cents net income for 2026, the only company profitable in this segment in 2026.
0 · Reply
Dietl
Dietl Jan. 28 at 11:13 PM
$CAI is thinly traded, with 282M shares outstanding, and 92M float. Out of the lockup, is it? Some bonehead sells the stock at 25.20 after hours.
1 · Reply
Dietl
Dietl Jan. 28 at 11:09 PM
$CAI $GH took a dump, what happened?
0 · Reply
Ron12341
Ron12341 Jan. 28 at 10:32 PM
$CAI My goal is it have 10K shares under $30 with $200 price targets in 5 years
0 · Reply
Latest News on CAI
Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering

May 23, 2025, 5:54 PM EDT - 9 months ago

Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering

Caris Life Sciences discloses rise in revenue in US IPO filing

May 23, 2025, 5:12 PM EDT - 9 months ago

Caris Life Sciences discloses rise in revenue in US IPO filing

Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO

May 23, 2025, 4:22 PM EDT - 9 months ago

Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO

Caris Life Sciences IPO Registration Document (S-1)

May 23, 2025, 3:27 PM EDT - 9 months ago

Caris Life Sciences IPO Registration Document (S-1)

Ron12341
Ron12341 Jan. 30 at 8:54 PM
$CAI About to test 52 weeks low. We need news from management not to be in free fall mode.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 29 at 11:12 PM
$CAI Share Price: $25.20 Contract Selected: Jul 17, 2026 $25 Calls Buy Zone: $3.06 – $3.78 Target Zone: $5.33 – $6.52 Potential Upside: 65% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Ron12341
Ron12341 Jan. 29 at 10:49 PM
$CAI it’s ping pong - $25-$27. We need to stay above $25. It will be prudent to break above $27.
0 · Reply
Ron12341
Ron12341 Jan. 29 at 5:53 PM
$CAI What a blood bath…tough day
1 · Reply
Dietl
Dietl Jan. 28 at 11:48 PM
$CAI 2026 forecast
0 · Reply
Dietl
Dietl Jan. 28 at 11:48 PM
$CAI at $996M, adjusted EBITA at 23%, which is $235M, and 47% of that as net income, I get $110M net income, or 40 cents per share, about 80% more than forecast, so I must have stretched that somewhere.
0 · Reply
Dietl
Dietl Jan. 28 at 11:36 PM
$CAI $281M in Q4 revenue with 62% GM, and about $120M in opex, which is about $54M in net income. They have added $43M to cash in Q4. 22 cents net income for 2026, the only company profitable in this segment in 2026.
0 · Reply
Dietl
Dietl Jan. 28 at 11:13 PM
$CAI is thinly traded, with 282M shares outstanding, and 92M float. Out of the lockup, is it? Some bonehead sells the stock at 25.20 after hours.
1 · Reply
Dietl
Dietl Jan. 28 at 11:09 PM
$CAI $GH took a dump, what happened?
0 · Reply
Ron12341
Ron12341 Jan. 28 at 10:32 PM
$CAI My goal is it have 10K shares under $30 with $200 price targets in 5 years
0 · Reply
Ron12341
Ron12341 Jan. 28 at 10:30 PM
$CAI just picked up 385 shares at 26.04 free discount. Almost holding 7K shares
0 · Reply
dbogyi
dbogyi Jan. 28 at 9:42 PM
$CAI @Dietl yes... - am I right stating that someone got the stock fall 5% by selling 364 shares AH? :D Don't get me wrong, I am holding a long position in this one and do believe in the company, but the neglect of their results is just insane. As for TEM - CAI is the right company instead, mass will realize at some point.
0 · Reply
Dietl
Dietl Jan. 28 at 12:57 PM
$CAI lack of coverage and lack of operational data is likely behind it, When they announce second Q profit in Q4 and start guiding 2026, things should get interesting, but right now it is rather too quiet. Decent target,
0 · Reply
Dietl
Dietl Jan. 28 at 12:46 PM
$CAI is anyone here?
0 · Reply
Dietl
Dietl Jan. 27 at 12:39 AM
$CAI hold and $30 from Canaccord, gave $80 and buy to TEM. CAI 1/3 debt, profitable,
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 2:27 AM
$CAI Share Price: $25.02 Contract Selected: Jul 17, 2026 $25 Calls Buy Zone: $2.98 – $3.68 Target Zone: $5.55 – $6.78 Potential Upside: 76% ROI Time to Expiration: 174 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Ron12341
Ron12341 Jan. 22 at 4:05 PM
$CAI Let’s keep the momentum going. We need more volume.
0 · Reply
Eskayes
Eskayes Jan. 22 at 3:24 PM
$GH this is probably and unfortunately going to get acquired. The writing is on the wall in the space. Hope they don’t honestly but $EXAS, $QGEN $GRAL... Just bought more $CAI
0 · Reply
Uraniumbuzz
Uraniumbuzz Jan. 22 at 1:35 PM
$CAI I have been buying the dips. A no brainer in my opinion
0 · Reply
appayip
appayip Jan. 21 at 8:52 PM
$CAI I don't think it has anything to do with watchers. Tempus has 20000, it droped too. All genetics testing stocks dropped together. this one is specially out of radar. I never saw anyone talk about this company. They will know after this increase %90-100, or someone famous add this to portfolio.
0 · Reply
G101SPM
G101SPM Jan. 20 at 7:29 PM
#SHOWETIME Caris Life Sciences, Inc. NRG Winter Semi Meeting (January 21) Scheduled to appear: $CAI Charles Schwab Corp Business Update Call (January 21) Scheduled to appear: $SCHW Acuity Inc. Annual General Meeting (January 21) Scheduled to appear: $AYI Karman Holdings Inc. Acquisition of Seemann Composites LLC and Materials Sciences LLC by Karman Holdings Inc Call (January 21) Scheduled to appear: $KRMN
1 · Reply
Ron12341
Ron12341 Jan. 16 at 5:26 AM
$CAI A company that will sell over a $1 billion next year with the growth they are having deserves a much higher price to sale ratio. I think a 15X sales is reasonable which puts it at $40 a share. We only have 829 watchers. The price will look a lot different when it reaches 5,000
0 · Reply